İbrahim Şahin

Biography

Associate Professor İbrahim Şahin is a European Board-certified clinical geneticist whose work spans cancer genetics, rare disease genomics and molecular diagnostic laboratory leadership. He holds certification from the European Board of Medical Genetics and has more than thirteen years of combined clinical, academic and laboratory experience.

He has established and directed genetic diagnostic laboratories in Türkiye and Bahrain, and has contributed to curriculum design and postgraduate supervision in clinical genetics and genomics. His laboratory work covers next-generation sequencing workflows, variant interpretation and quality management.

From 2021 to 2026, at the Arabian Gulf University in Bahrain, he established that country’s first molecular genetics next-generation sequencing laboratory, which was accredited by the College of American Pathologists (CAP). That accreditation was earned by the Bahrain laboratory during his earlier appointment there; it is not held by this department.

Education and specialty training

• 2012–2017 — Medical Genetics Residency Programme, Department of Medical Genetics, Atatürk University, School of Medicine
• 2004–2011 — Doctor of Medicine (MD), Dokuz Eylül University, School of Medicine

Academic and professional appointments

• 2026–present — Associate Professor, Department of Medical Genetics, Ankara Etlik City Hospital, University of Health Sciences
• 2021–2026 — Head of Molecular and Biochemical Genetics Laboratories, Assistant Professor and Consultant Clinical Geneticist, Princess Al-Jawhara Center for Molecular Medicine, Genetics and Inherited Disorders, Arabian Gulf University, Bahrain
• 2023–2024 — Head of Bahrain Oncology Centre Laboratory and Consultant Clinical Geneticist, King Hamad University Hospital, Bahrain
• 2019–2021 — Associate Director, Tissue Typing (HLA) Laboratory, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital
• 2017–2022 — Medical Geneticist, Department of Medical Genetics, Diagnostic Center for Genetic Diseases, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital
• 2017–2019 — Visiting Scientist, Cancer Systems Biology, Department of Molecular Biology and Genetics, Bilkent University
• 2012–2017 — Medical Geneticist, Department of Medical Genetics, Diagnostic Center for Genetic Diseases, Atatürk University, School of Medicine

Professional certifications

• 2023 — European Board of Medical Genetics (EBMGG)
• 2022 — Associate Professor in Medical Genetics, Ministry of Health, Türkiye
• 2017 — Medical Geneticist Diploma, Atatürk University Medical School
• 2011 — Medical School Diploma, Dokuz Eylül University Medical School

Academic and administrative responsibilities

Laboratory direction and accreditation readiness across molecular and biochemical genetics, covering next-generation sequencing workflows, whole-exome, whole-genome, panel and comprehensive genomic profiling analysis, standard operating procedure development and quality-control management. Curriculum design and course leadership in clinical genetics and genomics at MD, MSc, PhD and residency levels, together with postgraduate research supervision.

He is a member of the Turkish Society of Medical Genetics, the European Society of Human Genetics, the European Society for Medical Oncology and the International Society of Liquid Biopsy.

Selected publications

Chosen from the curriculum vitae to show the range of the work. Records already held in the department’s publication database appear in the section below this one and are not repeated here.

• Pehlivan D, Bayram Y, Gunes N, … Erdem HB, Sahin I, et al., Lupski JR. The genomics of arthrogryposis, a complex trait: candidate genes and further evidence for oligogenic inheritance. The American Journal of Human Genetics, 2019. doi:10.1016/j.ajhg.2019.05.015
• Al-Kafaji G, Jassim G, AlHajeri A, … Sahin I, Alali F, Fadel E. Investigation of germline variants in Bahraini women with breast cancer using next-generation sequencing based multigene panel. PLOS ONE, 2023. doi:10.1371/journal.pone.0291015
• Sahin I, Kandemir N, Saat H. Expanding the genotype–phenotype correlations in Alport syndrome: novel mutations, digenic inheritance and genetic modifiers. Egyptian Journal of Medical Human Genetics, 2023. doi:10.1186/s43042-023-00441-x
• Saat H, Sahin I, Erdem HB, Özgür S, Terlemez Tokgöz S, Bahsi T. Molecular approach of hereditary arrhythmias, long QT syndrome and arrhythmogenic right ventricular cardiomyopathy. The Anatolian Journal of Cardiology, 2022. doi:10.5152/anatoljcardiol.2022.1324
• Sahin I, Saat H. A novel BRCA1 duplication and new insights on the spectrum and frequency of germline large genomic rearrangements in BRCA1/BRCA2. Molecular Biology Reports, 2021. doi:10.1007/s11033-021-06499-3
• Sahin I, Saat H, Aksoy S, Dizdar Ö, Erdem HB, Bahsi T. Liquid biopsy: novel perspectives on the importance and spectrum of PIK3CA, PTEN and RET mutations in solid tumors. Molecular and Clinical Oncology, 2021. doi:10.3892/mco.2021.2434
• Sahin I, Saat H. Hereditary spastic paraplegia: new insights into clinical variability and spasticity–ataxia phenotype, and novel mutations. Acta Neurologica Belgica, 2021. doi:10.1007/s13760-021-01779-y
• Saat H, Sahin I. Mutation spectrum of hereditary myopathies in Turkish patients and novel variants. Annals of Human Genetics, 2021. doi:10.1111/ahg.12429
• Ceylan AC, Citli S, Erdem HB, Sahin I, Acar Arslan E, Erdogan M. Importance and usage of chromosomal microarray analysis in diagnosing intellectual disability, global developmental delay and autism. Molecular Cytogenetics, 2018. doi:10.1186/s13039-018-0402-4
• Tasdemir S, Sahin I, Çayır A, Yuce I, Ceylaner S, Tatar A. Vici syndrome in siblings born to consanguineous parents. American Journal of Medical Genetics Part A, 2016. doi:10.1002/ajmg.a.37398

The complete publication list, together with book chapters, appointments and certifications, is in the downloadable academic CV above.